Company overview

Encoded Therapeutics is creating one-time, disease-modifying gene therapies for pediatric central nervous system (CNS) disorders with its cell-selective targeting and regulation platform. The Encoded approach offers potentially unprecedented gene specificity and cell selectivity to unlock novel opportunities by targeting a range of disease mechanisms. Encoded’s technology is compatible with any delivery system to control where and when therapeutic transgenes are expressed, thereby shaping the functionality of target cells and holding broader therapeutic potential beyond CNS disorders. For more information, please visit www.encoded.com, and follow us on LinkedIn, Twitter @EncodedTx and YouTube. Social media guidelines: https://encoded.com/social-media-community-guidelines/
Founded in 2014
South San Francisco, California, USA
163 employees (3 in marketing)
69% recommend to a friend
59% positive business outlook

Salaries

Typical salary range

$150,000 – $190,000

/ yr

Help build salary transparency at Encoded Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount -7.4% year over year

Funding

Total funding

$239.1M

Last raise

Series D, 5 years ago

Funding history

Mar 2021

Series D Encoded Therapeutics

Jul 2020

Series D Encoded Therapeutics · $135M

Jun 2019

Series C Encoded Therapeutics · $104M

Jan 2015

Seed Round Encoded Therapeutics

Oct 2014

Convertible Note Encoded Therapeutics · $100K

Audience

Monthly website visitors
6.6K
Month over month-30.2%
Quarter over quarter-29.1%
Top sourceDirect (45.7%)
Ad budget per month$0.0
Average search rank37
Traffic source mix
Direct
45.7%
Search
30.6%
Social
15%
Referral
7.1%
Paid referral
1.5%

LinkedIn followers

Follower count and growth

Total followers

21.5K

12-mo growth

+19.7%

Monthly growth

+2.6%

News

Links